Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vertex Pharmaceutic 50 NORTHERN AVENUE BOSTON MA 02210 USA

P: 617-341-6100

Description:

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Key Statistics

Overview:

Market Capitalization, $K 46,678,120
Shares Outstanding, K 254,252
Annual Sales, $ 6,206 M
Annual Net Income, $ 2,712 M
Last Quarter Sales, $ 1,984 M
Last Quarter Net Income, $ 851,930 K
60-Month Beta 0.61
% of Insider Shareholders 0.70%
% of Institutional Shareholders 88.35%
Float, K 252,472
% Float 99.30%

Growth:

1-Year Return -16.14%
3-Year Return 10.39%
5-Year Return 147.96%
5-Year Revenue Growth 501.13%
5-Year Earnings Growth 536.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 3.56 on 11/02/21
Next Earnings Date N/A
Earnings Per Share ttm 10.81
EPS Growth vs. Prev Qtr 16.07%
EPS Growth vs. Prev Year 37.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 08/24/00

VRTX Ratios

Ratio
Price/Earnings ttm 17.23
Price/Earnings forward 77.38
Price/Earnings to Growth 1.56
Return-on-Equity % 31.03%
Return-on-Assets % 23.18%
Profit Margin % 43.70
Net Margin % -266.58
Debt/Equity 0.06
Price/Sales 7.63
Price/Cash Flow 19.45
Price/Book 4.97
Book Value/Share 37.49
Interest Coverage 54.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar